Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 25, 2025 11:01 ET | Source: Sobi, Inc.

Data presented at ACR Convergence 2025 highlight Sobi’s commitment to advancing care across rare and underserved inflammatory conditions

NASP data highlight reduction in disease burden among people living with uncontrolled gout Gamifant (emapalumab) data showed response rates in patients with MAS in Still’s disease across MAS...
May 24, 2024 16:15 ET | Source: Sobi, Inc.

Sobi to present new myelofibrosis data at the ASCO 2024 Annual Meeting

Sobi will present three abstracts that highlights data from its myelofibrosis treatment option at ASCO.